Patients need proof, not presumption
The regenerative medicine movement is finally finding its stride and emerging at a healthy pace, along with growing systems of support and accountability. Because of this progress, patients need now more than ever to be able to depend upon neutral interpretations of information. In this editorial, Doug Oliver responds to Leigh Turner’s recent interview and perspective on how, why and when cell therapy providers allegedly exploit ClinicalTrials.gov.
Please sign in or register for FREE
Sign in to RegMedNet
Register to RegMedNet
RegMedNet is a free content and networking hub promoting global connection, knowledge-sharing and collaboration between all members of the regenerative medicine field.